Clinical Trials Directory

Trials / Completed

CompletedNCT03871933

Autonomic Function in COPD and Risk for Atrial Fibrillation

Characterization of Autonomic Function in Patients With Chronic Obstructive Pulmonary Disease - Potential Relevance for Increased Risk of Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Heinrich-Heine University, Duesseldorf · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers

Summary

In the presented study, autonomic function as well as risk for atrial fibrillation will be assessed to characterize the relation between risk of atrial fibrillation and autonomic function.

Detailed description

Atrial fibrillation (AF) has been suggested as relevant comorbidity in patients with chronic obstructive pulmonary disease (COPD). The evaluation of the total atrial conduction time via tissue Doppler imaging (PA-TDI interval) can be used to identify patients with increased risk of new onset AF. Autonomic function can be assessed by different non invasive clinical investigations. The investigators hypothesise that PA-TDI interval is increased in acutely exacerbated COPD (AECOPD) compared within stable COPD and that increased PA-TDI is related to impairment of autonomic function. For this purpose, 25 patients with AECOPD and 25 patients with stable COPD were characterized by clinical characteristics, laboratory tests, lung function, electrocardiography, echocardiography and autonomic function.

Conditions

Interventions

TypeNameDescription
OTHERMeasurement of lung function, electrocardiography, echocardiography and autonomic functionMeasurement of lung function, electrocardiography, echocardiography and autonomic function

Timeline

Start date
2019-03-01
Primary completion
2019-08-31
Completion
2019-08-31
First posted
2019-03-12
Last updated
2019-11-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03871933. Inclusion in this directory is not an endorsement.